Arca
Skip to content
Tools
Tools

GenePOC CDiff

C. Difficile Toxin Gene Amplification Assay. 510(k) K172569, from Genepoc, Inc. (Quebec, CA). Product code OZN, class 2.

As of Nov 20, 2026, K172569 is an FDA 510(k) held by Genepoc, Inc., substantially equivalent on Nov 22, 2017 after 89 days, with 1 recall tied to it in FDA's recall database.

  • Review time: 89 days
  • Recalls: 1
  • Cited as a predicate by: 1 device

Indications for use

As the 510(k) summary states them, read from FDA's summary PDF

The GenePOC CDiff assay performed on the revogene instrument is a qualitative in vitro diagnostic test that utilizes automated sample processing and real-time polymerase chain reaction (PCR) to detect the toxin B (tcdB) gene of toxigenic Clostridium difficile (C. difficile) in unformed (liquid or soft) stool specimens obtained from patients suspected of having C. difficile infection (CDI).

Predicate devices

The legally marketed devices this 510(k) summary says it is substantially equivalent to, read from FDA's summary PDF

Cited as a predicate

1 later 510(k) summary names this device as a predicate

Recalls

Recalls FDA ties to K172569, newest first; recall numbers filed together for one problem share a row, and each opens FDA's recall record
StartedRecallStatus
Dec 5, 2025Z-1019-2026The affected lots show a decline in performance over time, which may lead to false-negative results.Open

Other OZN clearances

The newest 510(k)s for the same product code; their median review was 124 days; see every OZN device

Record

Type
Traditional
Received
Aug 25, 2017
Review panel
Microbiology
Regulation
21 CFR 866.3130

One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.